Skip Content
You are currently on the new version of our website. Access the old version .

99 Results Found

  • Article
  • Open Access
20 Citations
3,442 Views
11 Pages

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)

  • Agnieszka Nowak,
  • Brygida Przywara-Chowaniec,
  • Aleksandra Damasiewicz-Bodzek,
  • Dominika Blachut,
  • Ewa Nowalany-Kozielska and
  • Krystyna Tyrpień-Golder

13 December 2021

Systemic lupus erythematosus (SLE) is characterized by abnormal action of the immune system and a state of chronic inflammation. The disease can cause life-threatening complications. Neoepitopes arising from interdependent glycation and oxidation pro...

  • Review
  • Open Access
58 Citations
6,154 Views
28 Pages

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases

  • Mieke Steenbeke,
  • Reinhart Speeckaert,
  • Stéphanie Desmedt,
  • Griet Glorieux,
  • Joris R. Delanghe and
  • Marijn M. Speeckaert

Patients with chronic kidney disease (CKD) are more prone to oxidative stress and chronic inflammation, which may lead to an increase in the synthesis of advanced glycation end products (AGEs). Because AGEs are mostly removed by healthy kidneys, AGE...

  • Article
  • Open Access
35 Citations
4,564 Views
12 Pages

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD

  • Elena Dozio,
  • Simone Vettoretti,
  • Lara Caldiroli,
  • Silvia Nerini-Molteni,
  • Lorenza Tacchini,
  • Federico Ambrogi,
  • Piergiorgio Messa and
  • Massimiliano M. Corsi Romanelli

Advanced glycation end-products (AGE) can promote chronic kidney disease (CKD) progression and CKD-related morbidities. The soluble receptor for AGE (sRAGE) is a potential biomarker of inflammation and oxidative stress. Here, we explored the role of...

  • Article
  • Open Access
11 Citations
3,881 Views
19 Pages

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension

  • Franziska Diekmann,
  • Philippe Chouvarine,
  • Hannes Sallmon,
  • Louisa Meyer-Kobbe,
  • Moritz Kieslich,
  • Brian D. Plouffe,
  • Shashi K. Murthy,
  • Ralf Lichtinghagen,
  • Ekaterina Legchenko and
  • Georg Hansmann

10 August 2021

Pulmonary arterial hypertension (PAH) is a progressive condition with an unmet need for early diagnosis, better monitoring, and risk stratification. The receptor for advanced glycation end products (RAGE) is activated in response to hypoxia and vascu...

  • Communication
  • Open Access
3 Citations
2,051 Views
13 Pages

19 June 2023

Background: The soluble form of receptor for advanced glycation end products (sRAGE) have been implicated in the prevention of numerous pathologic states, and highlights as an attractive therapeutic target. Because diets rich in monounsaturated fatty...

  • Article
  • Open Access
11 Citations
3,720 Views
13 Pages

The interaction of advanced glycation end products (AGE) and their receptors promote vascular complications of diabetes in hemodialysis (HD) patients. The soluble form of the receptor for the advanced glycation end-products (sRAGE) has been studied a...

  • Article
  • Open Access
15 Citations
2,483 Views
16 Pages

12 December 2022

The interaction of advanced glycation end-products (AGEs) with their receptor (RAGE) elicits oxidative stress and inflammation, which is involved in the development of breast cancer. However, large-scale population-based evidence exploring geneticall...

  • Article
  • Open Access
19 Citations
8,008 Views
12 Pages

3 April 2013

This study aims to investigate potential diabetic retinopathy (DR) risk factors by evaluating the circulating levels of pentosidine, soluble receptor for advanced glycation end-product (sRAGE), advanced oxidation protein product (AOPP) as well as glu...

  • Article
  • Open Access
1,814 Views
11 Pages

31 January 2024

Acute lymphoblastic leukemias are the most common malignancies in childhood. Although its etiology is still unclear, it is thought that disorders in oxidative stress metabolism may contribute to leukemogenesis. Advanced glycation end products (AGEs)...

  • Article
  • Open Access
16 Citations
3,899 Views
11 Pages

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma

  • Alessandro Allegra,
  • Caterina Musolino,
  • Elisabetta Pace,
  • Vanessa Innao,
  • Eleonora Di Salvo,
  • Maria Ferraro,
  • Marco Casciaro,
  • Giovanna Spatari,
  • Gennaro Tartarisco and
  • Sebastiano Gangemi
  • + 1 author

Glycative stress influences tumor progression. The aim of the present study was to evaluate the advanced glycation end products/soluble receptor of advanced glycation end products (AGE/sRAGE) axis in patients with multiple myeloma (MM). Blood samples...

  • Article
  • Open Access
9 Citations
3,809 Views
10 Pages

The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts

  • Cristina Iulia Mitran,
  • Ilinca Nicolae,
  • Mircea Tampa,
  • Madalina Irina Mitran,
  • Constantin Caruntu,
  • Maria Isabela Sarbu,
  • Corina Daniela Ene,
  • Clara Matei,
  • Antoniu Cringu Ionescu and
  • Mircea Ioan Popa
  • + 1 author

20 October 2019

Background and objectives: Warts are the most common lesions caused by human papillomavirus (HPV). Recent research suggests that oxidative stress and inflammation are involved in the pathogenesis of HPV-related lesions. It has been shown that the sol...

  • Article
  • Open Access
12 Citations
3,438 Views
15 Pages

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes

  • James N. Tsoporis,
  • Erifili Hatziagelaki,
  • Sahil Gupta,
  • Shehla Izhar,
  • Vasileos Salpeas,
  • Anastasia Tsiavou,
  • Angelos G. Rigopoulos,
  • Andreas S. Triantafyllis,
  • John C. Marshall and
  • Ioannis K. Rizos
  • + 1 author

10 November 2020

We determined whether plasma concentrations of the receptor for advanced glycation end products (RAGE) and the soluble (s) form of RAGE (sRAGE) in healthy individuals and patients with type 2 diabetes (T2D) modulate vascular remodeling. Healthy indiv...

  • Review
  • Open Access
15 Citations
3,820 Views
21 Pages

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases

  • Charlotte Delrue,
  • Reinhart Speeckaert,
  • Joris R. Delanghe and
  • Marijn M. Speeckaert

2 February 2023

Advanced glycation end products (AGEs) are a class of compounds formed by nonenzymatic interactions between reducing sugars and proteins, lipids, or nucleic acids. AGEs can alter the protein structure and activate one of their receptors, specifically...

  • Article
  • Open Access
3 Citations
2,348 Views
27 Pages

Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus

  • Irene Carrión-Barberà,
  • Laura Triginer,
  • Laura Tío,
  • Carolina Pérez-García,
  • Anna Ribes,
  • Victoria Abad,
  • Ana Pros,
  • Jordi Monfort and
  • Tarek Carlos Salman-Monte

It has been postulated that advanced glycation end products (AGEs) and their soluble receptor (sRAGE) may play a relevant role as inducers in the chronic inflammatory pathway in various conditions, among them, in immune-mediated diseases such as syst...

  • Article
  • Open Access
7 Citations
2,621 Views
11 Pages

13 December 2022

Psoriasis is a chronic, recurrent, and often severe skin disease which is frequently associated with metabolic disorders and increased risk of cardiovascular complications. One of the postulated links is an intensified process of advanced protein gly...

  • Article
  • Open Access
8 Citations
2,782 Views
15 Pages

Changes in Plasma Soluble Receptor for Advanced Glycation End-Products Are Associated with Survival in Patients with Acute Respiratory Distress Syndrome

  • Matthieu Jabaudon,
  • Bruno Pereira,
  • Erwan Laroche,
  • Laurence Roszyk,
  • Raiko Blondonnet,
  • Jules Audard,
  • Thomas Godet,
  • Emmanuel Futier,
  • Jean-Etienne Bazin and
  • on behalf of the LIVE Study Group and the AZUREA Network
  • + 4 authors

12 May 2021

The plasma soluble receptor for advanced glycation end-products (sRAGE) is a marker of lung epithelial injury with prognostic value when measured at baseline in acute respiratory distress syndrome (ARDS). However, whether changes in plasma sRAGE coul...

  • Review
  • Open Access
5 Citations
4,545 Views
18 Pages

The Role of Advanced Glycation End-Products in the Pathophysiology and Pharmacotherapy of Cardiovascular Disease

  • Karina O. Mota,
  • Carla M. L. de Vasconcelos,
  • Lorrie A. Kirshenbaum and
  • Naranjan S. Dhalla

Advanced glycation end-products (AGEs) are formed by the non-enzymatic glycation of proteins, lipids, and nucleic acids due to the consumption of high-carbohydrate diets; their production is also promoted by a sedentary lifestyle as well as cigarette...

  • Article
  • Open Access
3 Citations
1,949 Views
10 Pages

16 September 2022

An abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta greater than 50% of the diameter of a healthy aorta. Previous experimental studies confirm the effect of calprotectin (CAL) on the onset of arterial pathology. It has been sugg...

  • Article
  • Open Access
2 Citations
2,527 Views
9 Pages

Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years

  • Julie Magnier,
  • Valérie Julian,
  • Vincent Sapin,
  • Aurélien Mulliez,
  • Alexandra Usclade,
  • Emmanuelle Rochette,
  • Bertrand Evrard,
  • André Labbe,
  • Karen Coste and
  • Carole Egron

10 June 2022

Background: Asthma is a chronic inflammatory disease of the airways common in children. Soluble advanced glycation end-product receptor (sRAGE) is a blood biomarker of lung damage and inflammation. We sought to determine whether it could also be a bi...

  • Article
  • Open Access
24 Citations
8,419 Views
18 Pages

A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway

  • Caixia Guo,
  • Xiangjun Zeng,
  • Juanjuan Song,
  • Min Zhang,
  • Hongxia Wang,
  • Xiaowei Xu,
  • Fenghe Du and
  • Buxing Chen

20 September 2012

Severe myocardial dysfunction and tissue damage resulting from ischemia/reperfusion (I/R) is a common clinical scenario in patients with certain types of heart diseases and therapies such as thrombolysis, percutaneous coronary intervention, coronary...

  • Article
  • Open Access
2 Citations
950 Views
20 Pages

Association Between Redox and Inflammatory Biomarkers with the Presence and Severity of Obstructive Sleep Apnea

  • Ana Ninić,
  • Branislava Rajkov,
  • Jelena Kotur-Stevuljević,
  • Sanja Erceg,
  • Miron Sopić,
  • Jelena Munjas,
  • Vesna Spasojević-Kalimanovska,
  • Marija Mitrović,
  • Lidija Memon and
  • Marija Zdravković
  • + 3 authors

29 August 2025

Background and Objectives: Obstructive sleep apnea (OSA) represents an increasing public health concern, closely linked with cardiovascular, metabolic, and neurocognitive disorders, as well as impaired quality of life. The complex pathophysiology of...

  • Article
  • Open Access
29 Citations
3,531 Views
8 Pages

Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers

  • Elena Dozio,
  • Clementina Sitzia,
  • Lara Pistelli,
  • Rosanna Cardani,
  • Roberta Rigolini,
  • Marco Ranucci and
  • Massimiliano M. Corsi Romanelli

23 November 2020

The receptor for advanced glycation end products (RAGE), a well-known player of diabetes mellitus (DM)-related morbidities, was supposed to be involved in coronavirus disease-19 (COVID-19), but no data exist about COVID-19, DM, and the soluble RAGE (...

  • Article
  • Open Access
3 Citations
2,475 Views
12 Pages

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study

  • Paolo Molinari,
  • Lara Caldiroli,
  • Elena Dozio,
  • Roberta Rigolini,
  • Paola Giubbilini,
  • Francesca Maria Ida Carminati,
  • Giuseppe Castellano,
  • Massimiliano M. Corsi Romanelli and
  • Simone Vettoretti

29 January 2023

Background: Chronic kidney disease (CKD) is characterized by an overproduction and accumulation of advanced glycation end products (AGEs). Because AGEs may play a role in the development of malnutrition and sarcopenia, two essential components of fra...

  • Article
  • Open Access
33 Citations
3,933 Views
10 Pages

1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease

  • Antonino Di Pino,
  • Francesca Urbano,
  • Roberto Scicali,
  • Stefania Di Mauro,
  • Agnese Filippello,
  • Alessandra Scamporrino,
  • Salvatore Piro,
  • Francesco Purrello and
  • Agata Maria Rabuazzo

16 August 2019

We investigated the correlation of the soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) with markers of cardiovascular disease in subjects with normal glucose tolerance (NGT) and 1 h postload glucose...

  • Article
  • Open Access
20 Citations
3,720 Views
12 Pages

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease

  • Paolo Molinari,
  • Lara Caldiroli,
  • Elena Dozio,
  • Roberta Rigolini,
  • Paola Giubbilini,
  • Massimiliano M. Corsi Romanelli,
  • Piergiorgio Messa and
  • Simone Vettoretti

15 December 2021

Patients with chronic kidney disease (CKD) are affected by enhanced oxidative stress and chronic inflammation, and these factors may contribute to increase advanced glycation end-products (AGEs). In this study we quantified AGEs and soluble receptors...

  • Article
  • Open Access
15 Citations
2,920 Views
12 Pages

Biomarkers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Active Nephritis

  • Lu Liu,
  • Karina de Leeuw,
  • Suzanne Arends,
  • Berber Doornbos-van der Meer,
  • Marian L. C. Bulthuis,
  • Harry van Goor and
  • Johanna Westra

17 August 2023

Oxidative stress plays an important role in systemic lupus erythematosus (SLE) and especially in lupus nephritis (LN). The aim of this study was to compare redox-related biomarkers between patients with active LN, quiescent SLE (Q-SLE) and healthy co...

  • Article
  • Open Access
6 Citations
2,738 Views
10 Pages

Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease

  • Paolo Molinari,
  • Lara Caldiroli,
  • Elena Dozio,
  • Roberta Rigolini,
  • Paola Giubbilini,
  • Massimiliano M. Corsi Romanelli,
  • Giuseppe Castellano and
  • Simone Vettoretti

Background: In patients with chronic kidney disease (CKD), there is an overproduction and accumulation of advanced glycation end-products (AGEs). Since AGEs may have detrimental effects on muscular trophism and performance, we evaluated whether they...

  • Article
  • Open Access
12 Citations
3,170 Views
13 Pages

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition

  • Lara Caldiroli,
  • Paolo Molinari,
  • Elena Dozio,
  • Roberta Rigolini,
  • Paola Giubbilini,
  • Massimiliano M. Corsi Romanelli,
  • Giuseppe Castellano and
  • Simone Vettoretti

Background: in patients with chronic kidney disease (CKD), the inflammatory and pro-oxidant milieu may contribute to malnutrition development. In this study, we investigated the relationship between inflammation, advanced glycation end-products (AGEs...

  • Article
  • Open Access
12 Citations
3,269 Views
16 Pages

Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits

  • Ioannis-Alexandros Drosatos,
  • James N. Tsoporis,
  • Shehla Izhar,
  • Sahil Gupta,
  • George Tsirebolos,
  • Eleftherios Sakadakis,
  • Andreas S. Triantafyllis,
  • Angelos Rigopoulos,
  • Dimitrios Rigopoulos and
  • Thomas G. Parker
  • + 2 authors

13 September 2021

Apart from its beneficial effects on cardiovascular risk factors, an anti-inflammatory effect of exercise is strongly implicated. Yet, data regarding the effect of an exercise intervention on healthy individuals are limited and contradictory. The pre...

  • Article
  • Open Access
27 Citations
3,989 Views
16 Pages

Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension

  • Bogna Gryszczyńska,
  • Magdalena Budzyń,
  • Beata Begier-Krasińska,
  • Angelika Osińska,
  • Maciej Boruczkowski,
  • Mariusz Kaczmarek,
  • Alicja Bukowska,
  • Maria Iskra and
  • Magdalena Paulina Kasprzak

13 August 2019

The aim of the present study was to evaluate advanced glycation end products (AGEs) and soluble form of receptor RAGE (sRAGE) concentrations as well as the AGEs/sRAGE ratio in mild (MH) and resistant (RH) hypertensive patients in comparison with norm...

  • Review
  • Open Access
37 Citations
18,621 Views
16 Pages

4 December 2015

PCOS is the most common cause of anovulation in reproductive-aged women with 70% experiencing ovulatory problems. Advanced glycation end products are highly reactive molecules that are formed by non-enzymatic reactions of sugars with proteins, nuclei...

  • Article
  • Open Access
1,317 Views
14 Pages

16 August 2025

Background/Objectives: Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by metabolic and hormonal imbalances in women of reproductive age. Various studies have emphasized that a diet high in advanced glycation end products (AGE...

  • Article
  • Open Access
4 Citations
2,347 Views
14 Pages

Significant Interrelations among Serum Annexin A1, Soluble Receptor for Advanced Glycation End Products (sRAGE) and rs2070600 in Chronic Obstructive Pulmonary Disease

  • Amira A. Kamel,
  • Maiada K. Hashem,
  • Ebtsam S. AbdulKareem,
  • Amal H. Ali,
  • Ekram Abdel-Rahman Mahmoud,
  • Alaa S. Abd-Elkader,
  • Hebatallah Abdellatif,
  • Alzahra Abdelbadea,
  • Nessren M. Abdel-Rady and
  • Marwa A. Dahpy
  • + 1 author

25 November 2022

Chronic obstructive pulmonary disease (COPD) is a major cause of death and morbidity; it may be accompanied by oxidative stress and inflammation with or without underlying genetic etiology. Finding circulating biomarkers for COPD that can help early...

  • Article
  • Open Access
1,480 Views
13 Pages

Success of an Inpatient Rehabilitation Program in Subjects with Type 2 Diabetes Mellitus with or Without Metabolic Syndrome

  • Bettina Thauerer,
  • Anna Odrovicsné Tóth,
  • Andreas Salzer and
  • Bibiane Steinecker-Frohnwieser

28 November 2024

Introduction: Type 2 diabetes mellitus (T2DM) comprises heterogeneous disorders, which have an increase in blood glucose concentrations in common. Metabolic syndrome (MetS) describes the simultaneous occurrence of several clinical symptoms that incre...

  • Article
  • Open Access
4 Citations
1,895 Views
10 Pages

18 May 2023

The receptor for advanced glycation end-products (RAGE) may serve as a diagnostic and prognostic biomarker of lung cancer and lung injury. We explored whether the serum and bronchial levels of soluble RAGE (sRAGE) distinguished infectious lung diseas...

  • Article
  • Open Access
5 Citations
3,443 Views
16 Pages

Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study

  • Fernando Rodríguez de Fonseca,
  • Francisco Medina-Paz,
  • Mira Sapozhnikov,
  • Isaac Hurtado-Guerrero,
  • Leticia Rubio,
  • Stella Martín-de-las-Heras,
  • Nerea Requena-Ocaña,
  • María Flores-López,
  • María del Mar Fernández-Arjona and
  • Juan Suárez
  • + 4 authors

29 February 2024

Alcohol use disorder (AUD) is a major component in the etiology of cognitive decline and dementia. Underlying mechanisms by which long-term alcohol abuse causes cognitive dysfunction include excessive oxidative stress and inflammation in the brain, a...

  • Article
  • Open Access
5 Citations
2,698 Views
16 Pages

15 July 2022

Tissue concentrations of advanced glycation end product (AGE) and peripheral soluble receptor of AGE (sRAGE) levels may be associated with periodontitis severity. Both parameters and periodontitis might serve as outcome predictors for patients underg...

  • Review
  • Open Access
9 Citations
3,157 Views
17 Pages

Dilatation of the aorta is a constantly evolving condition that can lead to the ultimate life-threatening event, acute aortic dissection. Recent research has tried to identify quantifiable biomarkers, with both diagnostic and prognostic roles in diff...

  • Review
  • Open Access
36 Citations
9,948 Views
17 Pages

Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease

  • Raphael S. Pinto,
  • Carlos A. Minanni,
  • Aécio Lopes de Araújo Lira and
  • Marisa Passarelli

22 February 2022

Epidemiological studies demonstrate the role of early and intensive glycemic control in the prevention of micro and macrovascular disease in both type 1 and type 2 diabetes mellitus (DM). Hyperglycemia elicits several pathways related to the etiopath...

  • Review
  • Open Access
19 Citations
3,109 Views
26 Pages

The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases

  • Elena Vianello,
  • Antonio P. Beltrami,
  • Aneta Aleksova,
  • Milijana Janjusevic,
  • Alessandra L. Fluca,
  • Massimiliano M. Corsi Romanelli,
  • Lucia La Sala and
  • Elena Dozio

The AGE (advanced glycation end-products)–RAGE (receptor for AGE) system is a pro-inflammatory pathway that contributes to the pathogenesis of obesity and obesity-related cardiovascular disorders (CVD). Circulating AGE and the soluble form of R...

  • Communication
  • Open Access
3 Citations
2,837 Views
10 Pages

No Glycation Required: Interference of Casein in AGE Receptor Binding Tests

  • Hannah E. Zenker,
  • Malgorzata Teodorowicz,
  • Harry J. Wichers and
  • Kasper A. Hettinga

9 August 2021

For the determination of the binding of heated cow’s milk whey proteins such as β-lactoglobulin to the receptors expressed on immune cells, inhibition ELISA with the soluble form of the receptor for advanced glycation end products (sRAGE) and scaveng...

  • Article
  • Open Access
24 Citations
4,203 Views
20 Pages

Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma

  • Corina Daniela Ene,
  • Mircea Nicolae Penescu,
  • Simona Roxana Georgescu,
  • Mircea Tampa and
  • Ilinca Nicolae

27 December 2020

Posttranslational modifications are dynamic enzymatic-mediated processes, regulated in time and space, associated with cancer development. We aimed to evaluate the significance of posttranslational modifications in the pathogenesis of clear cell rena...

  • Article
  • Open Access
8 Citations
3,167 Views
17 Pages

Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid

  • Bogna Gryszczyńska,
  • Magdalena Budzyń,
  • Dorota Formanowicz,
  • Maria Wanic-Kossowska,
  • Piotr Formanowicz,
  • Wacław Majewski,
  • Maria Iskra and
  • Magdalena P. Kasprzak

Our study aimed to identify the relationship between advanced glycation end products (AGEs), soluble receptor for advanced glycation end products (sRAGE), the AGEs/sRAGE, and uric acid (UA) levels in selected atherosclerosis diseases, i.e., abdominal...

  • Review
  • Open Access
1 Citations
2,077 Views
21 Pages

High-mobility group box 1 (HMGB1) is a nuclear protein that can interact with a transmembrane cell surface receptor for advanced glycation end products (RAGEs) and mediates the inflammatory pathways that lead to various pathological conditions like c...

  • Article
  • Open Access
10 Citations
2,968 Views
16 Pages

Human Adipose-Derived Stromal Cells Delivered on Decellularized Muscle Improve Muscle Regeneration and Regulate RAGE and P38 MAPK

  • Lucas C. Olson,
  • James T. Redden,
  • LaStar Gilliam,
  • Tri M. Nguyen,
  • Josephina A. Vossen,
  • David J. Cohen,
  • Zvi Schwartz and
  • Michael J. McClure

Volumetric muscle loss (VML) is the acute loss of muscle mass due to trauma. Such injuries occur primarily in the extremities and are debilitating, as there is no clinical treatment to restore muscle function. Pro-inflammatory advanced glycation end-...

  • Article
  • Open Access
17 Citations
3,538 Views
14 Pages

Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study

  • Maria Ferraro,
  • Serena Di Vincenzo,
  • Claudia Sangiorgi,
  • Stefania Leto Barone,
  • Sebastiano Gangemi,
  • Luigi Lanata and
  • Elisabetta Pace

11 February 2022

Patients with Chronic Obstructive Pulmonary Disease (COPD) periodically experience acute exacerbation (AECOPD). Carbocysteine represents a valid add on therapy in COPD by exerting antioxidant and anti-inflammatory activities. The in vivo effects of c...

  • Review
  • Open Access
57 Citations
13,275 Views
35 Pages

High molecular group box 1 (HMGB1) is a highly conserved member of the HMG-box-family; abundantly expressed in almost all human cells and released in apoptosis; necrosis or by activated immune cells. Once in the extracellular space, HMGB1 can act as...

  • Review
  • Open Access
7 Citations
4,631 Views
16 Pages

Novel Biomarkers Predictive of Diabetic Charcot Foot—An Overview of the Literature

  • Anca Bobircă,
  • Anca Emanuela Musetescu,
  • Anca Bordianu,
  • Anca Pantea Stoian,
  • Teodor Salmen,
  • Dan-Cristian Marinescu,
  • Cristina Alexandru,
  • Alesandra Florescu,
  • Raluca Radu and
  • Florin Bobircă
  • + 3 authors

21 November 2022

Background: Although Charcot diabetic foot (CDF) is a frequent complication of diabetic neuropathy, less is known about the possibility of its early prevention. Methods: A review of the original articles published in English, using the “biomark...

  • Article
  • Open Access
9 Citations
2,596 Views
11 Pages

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients

  • Aleksandra Damasiewicz-Bodzek,
  • Beata Łabuz-Roszak,
  • Bartłomiej Kumaszka,
  • Bartosz Tadeusiak and
  • Krystyna Tyrpień-Golder

Background: Advanced glycation end products (AGEs) are involved in the pathogenesis of many diseases, including neurodegenerative diseases such as multiple sclerosis (MS). The aim of the study was to determine serum concentrations of AGEs and their s...

  • Article
  • Open Access
38 Citations
8,970 Views
13 Pages

21 December 2010

Chronic mild stress (CMS) affects the hippocampal structure and function in the rat. S100B, a calcium-binding protein secreted by astrocytes, has been shown to be increased in serum of patients with depression and associated with good therapeutic res...

of 2